Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer U.S. Pension Plans by Quarter
U.S. Pension Plans — Net periodic benefit cost/(credit) ($M) ($M)
Pfizer U.S. Pension Plans: -$56M in Q2 2026, up 9.8% from a year earlier.
Latest, Q2 2026
-56
Period ended Jun 28, 2026
Change on a year earlier
+9.8%
-51 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
33
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Benefit Plans Footnote.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Pension Plans — Net periodic benefit cost/(credit) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | -56 | +9.8% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | -60 | +17.6% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | -123 | -138.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | -40 | -41.2% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | -51 | -26.1% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2025 | Mar 30, 2025 | -51 | -26.1% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 323 | -170.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | -68 | +17.2% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | -69 | +86.5% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | -69 | +91.7% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2023 | Dec 31, 2023 | -461 | +1,607.4% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2023 | Oct 1, 2023 | -58 | -75.3% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | -37 | -110.1% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | -36 | -80.6% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | -27 | -157.4% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2022 | Oct 2, 2022 | -235 | -76.1% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2022 | Jul 3, 2022 | 365 | -357.0% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2022 | Apr 3, 2022 | -186 | -0.5% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2021 | Dec 31, 2021 | 47 | -112.9% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2021 | Oct 3, 2021 | -983 | -189.4% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jul 4, 2021 | -142 | +19.3% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2021 | Apr 4, 2021 | -187 | -452.8% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2020 | Dec 31, 2020 | -365 | -325.3% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2020 | Sep 27, 2020 | 1,099 | -4,496.0% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2020 | Jun 28, 2020 | -119 | +340.7% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2020 | Mar 29, 2020 | 53 | -289.3% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2019 | Dec 31, 2019 | 162 | -485.7% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2019 | Sep 29, 2019 | -25 | -37.5% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | -27 | -44.9% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | -28 | -51.7% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2018 | Dec 31, 2018 | -42 | -146.7% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2018 | Sep 30, 2018 | -40 | -140.4% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2018 | Jul 1, 2018 | -49 | -171.0% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2018 | Apr 1, 2018 | -58 | -146.8% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 90 | – | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2017 | Oct 1, 2017 | 99 | – | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2017 | Jul 2, 2017 | 69 | – | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2017 | Apr 2, 2017 | 124 | – | Form 10-Q (filed 2018-05-10) ↗ |
Cite this data
StockData. (2026). Pfizer U.S. Pension Plans ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-cost-us
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.